Rezaie T - Search Results

1

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models.

Lipton SA, Rezaie T, Nutter A, Lopez KM, Parker J, Kosaka K, Satoh T, McKercher SR, Masliah E, Nakanishi N. Lipton SA, et al. Among authors: rezaie t. Cell Death Dis. 2016 Dec 1;7(12):e2499. doi: 10.1038/cddis.2016.389. Cell Death Dis. 2016. PMID: 27906174 Free PMC article.

2

Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration.

Rezaie T, McKercher SR, Kosaka K, Seki M, Wheeler L, Viswanath V, Chun T, Joshi R, Valencia M, Sasaki S, Tozawa T, Satoh T, Lipton SA. Rezaie T, et al. Invest Ophthalmol Vis Sci. 2012 Nov 27;53(12):7847-54. doi: 10.1167/iovs.12-10793. Invest Ophthalmol Vis Sci. 2012. PMID: 23081978 Free PMC article.

3

Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.

Satoh T, Rezaie T, Seki M, Sunico CR, Tabuchi T, Kitagawa T, Yanagitai M, Senzaki M, Kosegawa C, Taira H, McKercher SR, Hoffman JK, Roth GP, Lipton SA. Satoh T, et al. Among authors: rezaie t. J Neurochem. 2011 Nov;119(3):569-78. doi: 10.1111/j.1471-4159.2011.07449.x. Epub 2011 Sep 21. J Neurochem. 2011. PMID: 21883218 Free PMC article.

4

Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene.

Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, Brice G, Bhattacharya SS, Lehmann OJ, Sarfarazi M, Hitchings RA. Aung T, et al. Among authors: rezaie t. Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2816-22. doi: 10.1167/iovs.04-1133. Invest Ophthalmol Vis Sci. 2005. PMID: 16043855 Free article.

5

Molecular cloning and expression profiling of optineurin in the rhesus monkey.

Rezaie T, Waitzman DM, Seeman JL, Kaufman PL, Sarfarazi M. Rezaie T, et al. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2404-10. doi: 10.1167/iovs.04-1243. Invest Ophthalmol Vis Sci. 2005. PMID: 15980228

6

Optineurin in primary open angle glaucoma.

Sarfarazi M, Rezaie T. Sarfarazi M, et al. Among authors: rezaie t. Ophthalmol Clin North Am. 2003 Dec;16(4):529-41. doi: 10.1016/s0896-1549(03)00061-0. Ophthalmol Clin North Am. 2003. PMID: 14740994 Review.

7

Molecular cloning, genomic structure, and protein characterization of mouse optineurin.

Rezaie T, Sarfarazi M. Rezaie T, et al. Genomics. 2005 Jan;85(1):131-8. doi: 10.1016/j.ygeno.2004.10.011. Genomics. 2005. PMID: 15607428

8

Embryonic expression of the optineurin (glaucoma) gene in different stages of mouse development.

Rezaie T, Stoilov I, Sarfarazi M. Rezaie T, et al. Mol Vis. 2007 Aug 27;13:1446-50. Mol Vis. 2007. PMID: 17893645

9

Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Héon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M. Rezaie T, et al. Science. 2002 Feb 8;295(5557):1077-9. doi: 10.1126/science.1066901. Science. 2002. PMID: 11834836

10

Analysis of rare variants and common haplotypes in the optineurin gene in Swedish glaucoma cases.

Jansson M, Wadelius C, Rezaie T, Sarfarazi M. Jansson M, et al. Among authors: rezaie t. Ophthalmic Genet. 2005 Jun;26(2):85-9. doi: 10.1080/13816810490967953. Ophthalmic Genet. 2005. PMID: 16020311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page